Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|May 29, 2019
A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminomaJonathan Shamash, Rizwan Syed, Shah-Jalal Sarker, et al.
Gynecologic Oncology|July 14, 2020
Following chemotherapy for gestational trophoblastic neoplasia, do residual lung lesions increase the risk of relapse?Genevieve Bouchard-Fortier, Ehsan Ghorani, Dee Short, et al.
Cureus|October 10, 2025
Beginning of ABO-Incompatible Transplants in Pakistan: A Single-Centre ExperienceZaeema Ahmad, Andleeb Raja, Nubair Sarwar, et al.
Urologia Internationalis|October 27, 2010
The effect of sunitinib on immune subsets in metastatic clear cell renal cancerThomas Powles, Simon Chowdhury, Mark Bower, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2012
An indirect comparison of the toxicity of sunitinib and pazopanib in metastatic clear cell renal cancerThomas Powles, Naveed Sarwar, Rob Jones, et al.
Biosensors & Bioelectronics|April 16, 2025
Handheld ISFET Lab-on-Chip detection of YAP1 nucleic acid and AR-FL and AR-V7 mRNA from liquid biopsies for prostate cancer prognosisJoseph Broomfield, Melpomeni Kalofonou, Costanza Gulli, et al.
Acta Oncologica (Stockholm, Sweden)|September 5, 2012
Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminomaLaura Tookman, Sukaina Rashid, Athena Matakidou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2026
Comparison of efficacy and toxicity of 2 dactinomycin (ACTD) regimens in the second-line treatment of low-risk gestational trophoblastic neoplasia: a retrospective studyLeonoor T A Coopmans, Nienke E van Trommel, Sara Balduzzi, et al.
Gynecologic Oncology|August 4, 2019
When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patientsKirsty Balachandran, Abdulazeez Salawu, Ehsan Ghorani, et al.
The Oncologist|October 30, 2025
UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinomaSyed Hussain, Aisling Carr, Simon John Crabb, et al.
Pageof 5